X4 PHARMACEUTICALS INC's ticker is XFOR and the CUSIP is 98420X103. A total of 99 filers reported holding X4 PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.07 and the average weighting 0.2%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co. V, L.L.C. | 311,492 | $2,025,000 | 3.24% |
| AIGH Capital Management LLC | 1,438,899 | $9,353,000 | 1.68% |
| Ikarian Capital, LLC | 2,719,290 | $17,676,000 | 1.43% |
| Sio Capital Management, LLC | 804,597 | $5,230,000 | 1.30% |
| Bain Capital Life Sciences Investors, LLC | 2,119,540 | $13,777,000 | 0.90% |
| SV Health Investors, LLC | 311,490 | $2,025,000 | 0.88% |
| Worth Venture Partners, LLC | 334,684 | $2,175,000 | 0.81% |
| New Leaf Venture Partners, L.L.C. | 335,000 | $2,178,000 | 0.56% |
| Abingworth LLP | 229,885 | $1,494,000 | 0.46% |
| Monashee Investment Management LLC | 574,712 | $3,736,000 | 0.45% |